Institutional investors purchased a net $2.1 million shares of INSM during the quarter ended December 2013 and now own 75.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEERFIELD MANAGEMENT CO. LP Bought 2.0 Million shares of Insmed Inc
MILLENNIUM MANAGEMENT LLC Bought 62.6 Thousand shares of Insmed Inc
MARSHALL WACE LLP Bought 15.3 Thousand shares of Insmed Inc